Validation of a SARS-CoV-2 spike ELISA for use in contact investigations and serosurveillance
B. Freeman, S. Lester, L. Mills, M. A. U. Rasheed, S. Moye, O. Abiona, G. Hutchinson, M. Morales-Betoulle, I. Krapinunaya, A. Gibbons, C.-F. Chiang, D. Cannon, J. Klena, J. A. Johnson, S. M. Owen, , N. J. Thornburg
This study optimizes and validates a SARS-CoV-2 spike ELISA for use in contact investigations and serosurveillance, demonstrating its specificity and sensitivity.
bioRxiv · Apr 24, 2020 · PreprintImmunology